(Q53796684)

19 May 2018

title

Antibody levels achieved in infants by course of Haemophilus influenzae type B polysaccharide/diphtheria toxoid conjugate vaccine. (English)

1 reference

19 May 2018

1 reference

1 reference

Haemophilus influenzae

object named as

Haemophilus influenzae

1 reference

2

H Käyhty

1 reference

19 May 2018

author name string

J Eskola

1

1 reference

19 May 2018

H Peltola

3

1 reference

19 May 2018

V Karanko

4

1 reference

19 May 2018

P H Mäkelä

5

1 reference

19 May 2018

J Samuelson

6

1 reference

19 May 2018

L K Gordon

7

1 reference

19 May 2018

language of work or name

English

0 references

publication date

1 May 1985

1 reference

19 May 2018

published in

The Lancet

1 reference

19 May 2018

volume

1

1 reference

19 May 2018

page(s)

1184-1186

1 reference

19 May 2018

issue

8439

1 reference

19 May 2018

Increase in Influenzal Meningitis

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2885%2992863-6

7 January 2021

Haemophilus influenzae disease in Alaskan Eskimos: characteristics of a population with an unusual incidence of invasive disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2885%2992863-6

7 January 2021

Systemic Haemophilus influenzae infection in Finland

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2885%2992863-6

7 January 2021

Haemophilus influenzae meningitis. A national study of secondary spread in household contacts

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2885%2992863-6

7 January 2021

Letter: Ampicillin-resistant Haemophilus influenzae

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2885%2992863-6

7 January 2021

Meningitis due to Haemophilus influenzae type b resistant to ampicillin and chloramphenicol

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2885%2992863-6

7 January 2021

Immunization of Humans with Polyribophosphate, the Capsular Antigen of Hemophilus influenzae, Type b

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2885%2992863-6

7 January 2021

Prevention of Hemophilus influenzae type b bacteremic infections with the capsular polysaccharide vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2885%2992863-6

7 January 2021

Antibody responses to Haemophilus influenzae type b and diphtheria toxin induced by conjugates of oligosaccharides of the type b capsule with the nontoxic protein CRM197.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2885%2992863-6

7 January 2021

Further studies on the immunogenicity of Haemophilus influenzae type b and pneumococcal type 6A polysaccharide-protein conjugates

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2885%2992863-6

7 January 2021

Safety and Immunogenicity of Haemophilus influenzae Type B Polysaccharide-Diphtheria Toxoid Conjugate Vaccine in Adults

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2885%2992863-6

7 January 2021

Immunogenicity of Haemophilus influenzae type b polysaccharide--diphtheria toxoid conjugate vaccine in adults

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2885%2992863-6

7 January 2021

Safety and immunogenicity of Haemophilus influenzae type b-polysaccharide diphtheria toxoid conjugate vaccine in infants 9 to 15 months of age.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2885%2992863-6

7 January 2021

The protective level of serum antibodies to the capsular polysaccharide of Haemophilus influenzae type b

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2885%2992863-6

7 January 2021

10.1016/S0140-6736(85)92863-6

Identifiers

DOI

1 reference

19 May 2018

PubMed ID

2860387

1 reference

19 May 2018